Jump to content

Talk:Biological response modifier

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Improve intro and structure

[edit]

[1] seems to have a better overview.

We could group them by target (eg TNF-a).

Actemra/tocilizumab (an anti-IL6) is also considered a BRM. Rod57 (talk) 16:17, 9 March 2010 (UTC)[reply]